Detalles de la búsqueda
1.
Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with COVID-19: an open-label randomized controlled trial.
Respir Res
; 23(1): 202, 2022 Aug 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35945604
2.
Phase 1/1b Studies of UCB0599, an Oral Inhibitor of α-Synuclein Misfolding, Including a Randomized Study in Parkinson's Disease.
Mov Disord
; 37(10): 2045-2056, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35959805
3.
Comparative Therapeutic Potential of ALX-0171 and Palivizumab against Respiratory Syncytial Virus Clinical Isolate Infection of Well-Differentiated Primary Pediatric Bronchial Epithelial Cell Cultures.
Antimicrob Agents Chemother
; 64(2)2020 01 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-31767728
4.
High Throughput Combinatorial Formatting of PcrV Nanobodies for Efficient Potency Improvement.
J Biol Chem
; 291(29): 15243-55, 2016 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27226529
5.
Involvement of Fcα/µ Receptor in IgM Anti-Platelet, but Not Anti-Red Blood Cell Autoantibody Pathogenicity in Mice.
J Immunol
; 195(9): 4171-5, 2015 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26385523
6.
Trivalency of a Nanobody Specific for the Human Respiratory Syncytial Virus Fusion Glycoprotein Drastically Enhances Virus Neutralization and Impacts Escape Mutant Selection.
Antimicrob Agents Chemother
; 60(11): 6498-6509, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27550346
7.
Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus Infection.
Antimicrob Agents Chemother
; 60(1): 6-13, 2016 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26438495
8.
Antibody-independent thrombocytopenia in lactate dehydrogenase-elevating virus-infected mice.
J Virol
; 86(22): 12414-6, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22933286
9.
Nebulised ALX-0171 for respiratory syncytial virus lower respiratory tract infection in hospitalised children: a double-blind, randomised, placebo-controlled, phase 2b trial.
Lancet Respir Med
; 9(1): 21-32, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33002427
10.
Zilucoplan in patients with acute hypoxic respiratory failure due to COVID-19 (ZILU-COV): A structured summary of a study protocol for a randomised controlled trial.
Trials
; 21(1): 934, 2020 Nov 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-33213529
11.
Delivery of ALX-0171 by inhalation greatly reduces respiratory syncytial virus disease in newborn lambs.
MAbs
; 10(5): 778-795, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29733750
12.
Two-step mechanism of virus-induced autoimmune hemolytic anemia.
Ann N Y Acad Sci
; 1109: 151-7, 2007 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-17785301
13.
Nanobodies® as inhaled biotherapeutics for lung diseases.
Pharmacol Ther
; 169: 47-56, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27373507
14.
Enhancement of autoantibody pathogenicity by viral infections in mouse models of anemia and thrombocytopenia.
Autoimmun Rev
; 4(4): 247-52, 2005 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-15893720
15.
Kinetics of Respiratory Syncytial Virus (RSV) Memphis Strain 37 (M37) Infection in the Respiratory Tract of Newborn Lambs as an RSV Infection Model for Human Infants.
PLoS One
; 10(12): e0143580, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26641081
16.
Characterization of the T-lymphocyte response elicited by mouse immunization with rat platelets.
Exp Hematol
; 39(6): 676-85, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21397657
17.
Immunoglobulin M antiplatelet autoantibodies from mice immunized with rat platelets induce thrombocytopenia and platelet function impairment.
Exp Biol Med (Maywood)
; 235(12): 1464-71, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-21127343
Resultados
1 -
17
de 17
1
Próxima >
>>